BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33927108)

  • 21. Sarcomas: Immune biomarker expression and checkpoint inhibitor trials.
    Zhu MMT; Shenasa E; Nielsen TO
    Cancer Treat Rev; 2020 Dec; 91():102115. PubMed ID: 33130422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics.
    Jour G; Scarborough JD; Jones RL; Loggers E; Pollack SM; Pritchard CC; Hoch BL
    Hum Pathol; 2014 Aug; 45(8):1563-71. PubMed ID: 24908143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer.
    Morganti S; Tarantino P; Ferraro E; D'Amico P; Duso BA; Curigliano G
    Adv Exp Med Biol; 2019; 1168():9-30. PubMed ID: 31713162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial.
    Italiano A; Dinart D; Soubeyran I; Bellera C; Espérou H; Delmas C; Mercier N; Albert S; Poignie L; Boland A; Bourdon A; Geneste D; Cavaille Q; Laizet Y; Khalifa E; Auzanneau C; Squiban B; Truffaux N; Olaso R; Gerber Z; Wallet C; Bénard A; Blay JY; Laurent-Puig P; Deleuze JF; Lucchesi C; Mathoulin-Pelissier S;
    BMC Cancer; 2021 Nov; 21(1):1180. PubMed ID: 34740331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Next-generation sequencing-based clinical sequencing: toward precision medicine in solid tumors.
    Wakai T; Prasoon P; Hirose Y; Shimada Y; Ichikawa H; Nagahashi M
    Int J Clin Oncol; 2019 Feb; 24(2):115-122. PubMed ID: 30515675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotherapy for sarcomas.
    Nakata E; Fujiwara T; Kunisada T; Ito T; Takihira S; Ozaki T
    Jpn J Clin Oncol; 2021 Apr; 51(4):523-537. PubMed ID: 33611603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct genomic landscapes in radiation-associated angiosarcoma compared with other radiation-associated sarcoma histologies.
    Dermawan JK; Chi P; Tap WD; Rosenbaum E; D'Angelo S; Alektiar KM; Antonescu CR
    J Pathol; 2023 Aug; 260(4):465-477. PubMed ID: 37350195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study.
    Antoniotti C; Korn WM; Marmorino F; Rossini D; Lonardi S; Masi G; Randon G; Conca V; Boccaccino A; Tomasello G; Passardi A; Swensen J; Ugolini C; Oberley M; Tamburini E; Casagrande M; Domenyuk V; Fontanini G; Giordano M; Abraham J; Spetzler D; Falcone A; Lenz HJ; Cremolini C
    Eur J Cancer; 2021 Sep; 155():73-84. PubMed ID: 34365081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive genomic profiling for oncological advancements by precision medicine.
    Pankiw M; Brezden-Masley C; Charames GS
    Med Oncol; 2023 Nov; 41(1):1. PubMed ID: 37993657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microsatellite instability status determined by next-generation sequencing and compared with PD-L1 and tumor mutational burden in 11,348 patients.
    Vanderwalde A; Spetzler D; Xiao N; Gatalica Z; Marshall J
    Cancer Med; 2018 Mar; 7(3):746-756. PubMed ID: 29436178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma.
    Gounder MM; Agaram NP; Trabucco SE; Robinson V; Ferraro RA; Millis SZ; Krishnan A; Lee J; Attia S; Abida W; Drilon A; Chi P; Angelo SP; Dickson MA; Keohan ML; Kelly CM; Agulnik M; Chawla SP; Choy E; Chugh R; Meyer CF; Myer PA; Moore JL; Okimoto RA; Pollock RE; Ravi V; Singh AS; Somaiah N; Wagner AJ; Healey JH; Frampton GM; Venstrom JM; Ross JS; Ladanyi M; Singer S; Brennan MF; Schwartz GK; Lazar AJ; Thomas DM; Maki RG; Tap WD; Ali SM; Jin DX
    Nat Commun; 2022 Jun; 13(1):3406. PubMed ID: 35705558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
    Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
    Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using biology to guide the treatment of sarcomas and aggressive connective-tissue tumours.
    Dufresne A; Brahmi M; Karanian M; Blay JY
    Nat Rev Clin Oncol; 2018 Jul; 15(7):443-458. PubMed ID: 29666441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative Genomic Tests in Clinical Oncology.
    Imyanitov E; Sokolenko A
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations.
    Miller TI; Zoumberos NA; Johnson B; Rhodes DR; Tomlins SA; Chan MP; Andea AA; Lucas DR; McHugh JB; Smith N; Harms KL; Brewer C; Saleh J; Patel RM; Harms PW
    Hum Pathol; 2020 Aug; 102():60-69. PubMed ID: 32540221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulatory perspectives on next-generation sequencing and complementary diagnostics in Japan.
    Shimazawa R; Ikeda M
    Expert Rev Mol Diagn; 2020 Jun; 20(6):601-610. PubMed ID: 32064968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic Profiling and Clinical Outcomes of Targeted Therapies in Adult Patients with Soft Tissue Sarcomas.
    Kokkali S; Georgaki E; Mandrakis G; Valverde C; Theocharis S
    Cells; 2023 Nov; 12(22):. PubMed ID: 37998367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mutational pattern of homologous recombination-related (HRR) genes in Chinese colon cancer and its relevance to immunotherapy responses.
    Zhou P; Wu X; Chen H; Hu Y; Zhang H; Wu L; Yang Y; Mao B; Wang H
    Aging (Albany NY); 2020 Dec; 13(2):2365-2378. PubMed ID: 33318301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical applications of next-generation sequencing in colorectal cancers.
    Kim TM; Lee SH; Chung YJ
    World J Gastroenterol; 2013 Oct; 19(40):6784-93. PubMed ID: 24187453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.